InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
56,905.91
(
-2.39%
)
Post# of 114148
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

swampboots

Send PM Follow Ignore
Followers 183
Posts 30024
Boards Moderated 3
Alias Born 07/09/2003

swampboots

Member Level

Re: maxluke1 post# 98898

Thursday, 07/07/2022 12:03:09 PM

Thursday, July 07, 2022 12:03:09 PM

Post# of 114148
NEXI: I like DTIL better 1.53, both do allogeneic cell therapy,, both have some insider buying, but DTIL has revenue ,partners and cash to 2024 as just did the dilutive pipe sure shot dive.
I am no scientist so have to believe Novartis and Lilly picked over the important substance only computation rigor could discern.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up